Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Completed · Phase 3 · Has a placebo group
Conditions studied: Metastatic Cancer, Prostate Cancer
In brief
RATIONALE: Zoledronate may prevent or decrease skeletal (bone)-related events (such as pain or fractures) caused by bone metastases and androgen deprivation therapy. It is not yet known whether treatment with zoledronate is effective in preventing bone-related events in patients who have prostate cancer and bone metastases. PURPOSE: This randomized phase III trial is studying how well zoledronate works in preventing bone-related events in patients who are receiving androgen deprivation therapy for prostate cancer and bone metastases.
Key facts
- Study ID
- NCT00079001
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 645
- Starts
- 2004-01-01
- Expected to finish
- 2014-10-01
- Last updated by the study team
- 2020-05-12
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center — Fort Smith, Arkansas, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
- Veterans Affairs Medical Center - Loma Linda (Pettis) — Loma Linda, California, United States
- Study site — Pismo Beach, California, United States
- Robert and Beverly Lewis Family Cancer Care Center at Pomona Valley Hospital Medical Center — Pomona, California, United States
- Salinas Valley Memorial Hospital — Salinas, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States
- Saint Helena Hospital — St. Helena, California, United States
- Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital — Whittier, California, United States
- Yale Cancer Center — New Haven, Connecticut, United States
- Veterans Affairs Medical Center - West Haven — West Haven, Connecticut, United States
- Kaiser Permanente at Capitol Hill Medical Center — Washington D.C., District of Columbia, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia, United States
- Leesburg Regional Medical Center — Leesburg, Florida, United States
- Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler — Savannah, Georgia, United States
- Cancer Research Center of Hawaii — Honolulu, Hawaii, United States
- OnCare Hawaii, Incorporated - Lusitana — Honolulu, Hawaii, United States
- Queen's Cancer Institute at Queen's Medical Center — Honolulu, Hawaii, United States
- Straub Clinic and Hospital, Incorporated — Honolulu, Hawaii, United States
- Hawaii Medical Center - East — Honolulu, Hawaii, United States
- OnCare Hawaii, Incorporated - Kuakini — Honolulu, Hawaii, United States
- Kapiolani Medical Center for Women and Children — Honolulu, Hawaii, United States
- Pacific Cancer Institute - Maui — Wailuku, Hawaii, United States
- Kapiolani Medical Center at Pali Momi — ‘Aiea, Hawaii, United States
- Providence Cancer Center at Providence Hospital — Mobile, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.